Supernus Pharmaceuticals
SUPN
SUPN
233 hedge funds and large institutions have $1.59B invested in Supernus Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 90 increasing their positions, 67 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
233
Holders Change
+11
Holders Change %
+4.95%
% of All Funds
3.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
43
Increased
90
Reduced
67
Closed
28
Calls
$2.84M
Puts
$3.95M
Net Calls
-$1.11M
Net Calls Change
-$6.27M
Top Buyers
Top Sellers
| 1 |
BlackRock
New York
|
$246M |
| 2 |
Millennium Management
New York
|
$2.67M |
| 3 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
$0 |
| 4 |
Invesco
Atlanta,
Georgia
|
$21.7M |
| 5 |
Renaissance Technologies
New York
|
$36.1M |
